Mini E. Jacob, Box 356560,1959 NE Pacific Street, Seattle WA 98195, Phone: 412-996-8778,
J Frailty Aging. 2022;11(3):291-298. doi: 10.14283/jfa.2022.17.
Pragmatic biomarkers of preclinical dementia would allow for easy and large-scale screening of risk in populations. Physical function measures like grip strength and gait speed are potential predictive biomarkers but their relationship with plasma markers of Alzheimer's Disease and neurodegeneration have not been elucidated.
To examine association between physical function measures and plasma markers of Alzheimer's Disease (AD) and neurodegeneration.
Cross-sectional and longitudinal analyses.
Community-based cohort in the city of Framingham, Massachusetts.
2336 participants of the Framingham Heart Study Offspring cohort with an average age of 61.
Plasma Aβ40 and Aβ42 were measured in 1998-2001 (Exam-7) and plasma total tau measured 5 years later (Exam-8). Grip strength, fast walk speed and chair stand speed were measured at both exams. Quantification of Aβ isoforms in plasma was performed using INNO-BIA assays and plasma total-tau was measured using Quanterix Simoa HD-1 assay. Confounder-adjusted linear regression models examined associations between physical function and plasma markers, Results: Grip strength at Exam-7 was associated with plasma Aβ40 (β -0.006, p-value 0.032) at Exam-7 and plasma total-tau (β -0.010, p-value 0.001) at Exam-8. Grip strength and fast walk speed at Exam-8 were associated with plasma total-tau at Exam-8 (GS: β -0.009, p 0.0005; FWS: β -0.226, p-value <0.0001). Chair stand speed was not associated with plasma markers; Aβ42 was not associated with function.
Grip strength and fast walk speed are associated with plasma markers of neurodegeneration in dementia-free middle aged and older individuals. Both these measures could be used as potential screening tools for identifying individuals at a higher risk for AD and related dementias alongside other validated markers.
临床前痴呆症的实用生物标志物可以方便且大规模地筛选人群的风险。握力和步速等身体功能测量是潜在的预测生物标志物,但它们与阿尔茨海默病和神经退行性变的血浆标志物之间的关系尚未阐明。
检查身体功能测量与阿尔茨海默病(AD)和神经退行性变的血浆标志物之间的关联。
横断面和纵向分析。
马萨诸塞州弗雷明汉市的社区为基础的队列。
2336 名弗雷明汉心脏研究后代队列的参与者,平均年龄为 61 岁。
1998-2001 年(检查-7)测量血浆 Aβ40 和 Aβ42,5 年后(检查-8)测量血浆总 tau。两次检查均测量握力、快走速度和椅子站立速度。使用 INNO-BIA 测定法对血浆中的 Aβ 同工型进行定量,使用 Quanterix Simoa HD-1 测定法测量血浆总 tau。在调整混杂因素的线性回归模型中,检查了身体功能与血浆标志物之间的关系。结果:检查-7 时的握力与检查-7 时的血浆 Aβ40(β-0.006,p 值 0.032)和检查-8 时的血浆总 tau(β-0.010,p 值 0.001)呈负相关。检查-8 时的握力和快走速度与检查-8 时的血浆总 tau 呈负相关(GS:β-0.009,p<0.0005;FWS:β-0.226,p<0.0001)。椅子站立速度与血浆标志物无关联;Aβ42 与功能无关。
在无痴呆的中年和老年人中,握力和快走速度与神经退行性变的血浆标志物相关。这两种措施都可以用作识别 AD 及相关痴呆风险较高个体的潜在筛查工具,与其他经过验证的标志物一起使用。